Immunodiagnostic Systems Holdings PLC (hereafter referred to as IDS) is a leading in-vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture, and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields. IDS was founded in 1977 and trades on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. We are a global company headquartered in the UK with around 350 employees worldwide. Our products are developed and manufactured at our facilities in Europe. We serve our customers through regional offices in Europe, the USA and Brazil. Our network of distributors work on our behalf to serve our customers throughout the rest of the world.
Editors [1]
The following is the list of scholars from Immunodiagnostics Systems GmbH, who currently serve as editors for one or more SciTechnol journals.
Publications [24]
The following is the list of articles by scholars from Immunodiagnostics Systems GmbH, that are published in SciTechnol journals.
-
Neurotechnology: Innovations in Medical Biotechnology for Brain Disorders
Short Communication: Arch Med Biotechnol
DOI:
Angelo Luzia
-
Regenerative Medicine Using Stem Cell-Based Therapies
Short Communication: Arch Med Biotechnol
DOI:
Susma Pandey
-
Gene Therapy in the Treatment of Genetic Disorders
Commentary: Arch Med Biotechnol
DOI:
Aldeno Chang
-
Clinical Applications of Stem Cell Analysis and Ethical Concerns
Perspective: Arch Med Biotechnol
DOI:
Jing Chung
-
Molecular Diagnostics: Exploring the Genetic Landscape of Cancer
Opinion Article: Arch Med Biotechnol
DOI:
Jahson Mayer
-
Optimizing Drug Delivery by Deploying Nanomaterials
Opinion Article: Arch Med Biotechnol
DOI:
Josaph Crotel
-
Biosensors: Innovations in Disease Detection and Monitoring
Perspective: Arch Med Biotechnol
DOI:
Micael Lechano
-
Nanomedicine: Advancements in Targeted Drug Delivery
Commentary: Arch Med Biotechnol
DOI:
Kharel Mena
-
Biopharmaceuticals: From Development to Clinical Applications
Opinion Article: Arch Med Biotechnol
DOI:
Minda Lin
-
Personalized Medicine: The Role of Genomics and Biomarkers
Commentary: Arch Med Biotechnol
DOI:
Amiu Haliad
-
CRISPR-Cas9: A Revolution in Precision Genetic Analysis
Commentary: Arch Med Biotechnol
DOI:
-
Decoding the Human Genome: Insights into Biological Identity
Perspective: Arch Med Biotechnol
DOI:
Daniel Mariana
-
Display a Technique in Which No Tool is added into a Affected Person's Body
Perspective: Arch Med Biotechnol
DOI:
Rajan Kumar
-
Nanotechnology in Medical Biotechnology: From Diagnosis to Treatment
Perspective: Tabriz University of Medical Sciences,
DOI:
Amelie Fredrik
-
Biomimetic Approaches to Tissue Engineering: Mimicking Nature for Tissue Repair
Opinion Article: Arch Med Biotechnol
DOI:
Marwa Elnahas
-
Biopharmaceuticals: The Role of Medical Biotechnology in Drug Development
Opinion Article: Arch Med Biotechnol
DOI:
Stefen Erikson
-
The Efficacy of Virtual Reality Therapy in Pain Management Compared to Traditional Pain Management Techniques
Perspective: Arch Med Biotechnol
DOI:
Andrea Espin
-
Patient Experience and Strategies to Improve Patient Comfort and Reduce Anxiety during MRI Procedures
Perspective: Arch Med Biotechnol
DOI:
Hiroya Zhang
-
Empowering Patients with Mobile ECG Monitors: The Future of Remote Heart Monitoring
Perspective: Arch Med Biotechnol
DOI:
David Schram
-
Innovations in Biotechnology: Emerging Technologies and Future Possibilities
Opinion Article: Arch Med Biotechnol
DOI:
Neilsen Kampers
-
Enhancing Communication and Control in Paralysis Patients with Brain-Computer Interfaces
Opinion Article: Arch Med Biotechnol
DOI:
Damein Leonardo
-
Demonstrative Steadfast First-Rate Within the Space of Radiology
Commentary: Arch Med Biotechnol
DOI:
Li Jie
-
The Problems of Early Life Tuberculosis Prognosis
Commentary: Arch Med Biotechnol
DOI:
Raju Kumar
-
Recent Strategies for Diagnosis of Nontuberculous Mycobacteria Infections
Perspective: Arch Med Biotechnol
DOI:
Anand Rao